Product Description
Oxemia 50mg is a prescription tablet containing Desidustat 50mg, a HIF-PH (hypoxia-inducible factor prolyl hydroxylase) inhibitor made by Zydus. It is prescribed for anemia associated with chronic kidney disease (CKD) in adults, including patients on dialysis and those not yet on dialysis. It must be used only under the supervision of a registered medical practitioner with regular hemoglobin monitoring.
Key Benefits
Oral treatment for anemia caused by chronic kidney disease
Helps stimulate the body's own red blood cell and hemoglobin production
Helps the body make better use of its stored iron
Used in both dialysis and non-dialysis CKD patients, as prescribed
Tablet form, an alternative to injectable anemia therapy where the doctor considers it suitable
Made in India by Zydus
Key Ingredients & Their Uses
Desidustat 50mg: Blocks the HIF prolyl hydroxylase enzyme, which raises HIF levels in the body. This signals the body to produce erythropoietin, make more red blood cells and improve iron use, which helps correct CKD-related anemia.
How to Use
Take exactly as prescribed by your doctor. The dose is individualised and adjusted based on hemoglobin levels.
Swallow the tablet whole with water.
Regular blood tests (hemoglobin and safety parameters) are needed during treatment.
Effects build gradually over weeks. Do not change or stop the dose without medical advice.
If you miss a dose, follow your doctor's advice. Do not double the next dose.
Technical Specifications
Brand: Oxemia
Product Name: Oxemia 50mg Tablet
Product Type: Prescription HIF-PH Inhibitor for CKD Anemia (Allopathic)
Composition: Desidustat 50mg
Dosage Form: Tablet
Net Quantity: Strip of 6 Tablets
Pack Type: Strip
Suitable For: Adults with chronic kidney disease anemia, as prescribed by a doctor
Storage: Store at room temperature, away from moisture and light. Do not freeze
Country of Origin: India
Manufacturer: Zydus Lifesciences Limited (Zydus Cadila), Zydus Corporate Park, Khoraj, Ahmedabad, Gujarat